BP, Q4 and Capital Market
BP warns of fourth-quarter profit hit, postpones capital markets day
BP warned that its fourth-quarter results will be hit by weaker oil and gas production, refining margins and trading, while also delaying a highly-anticipated investor day due to a medical procedure undergone by CEO Murray Auchincloss.
A judge has dismissed New York City's lawsuit alleging that Exxon Mobil , BP and Shell were liable for misleading the public ...
The British oil-and-gas giant said the non-cash, post-tax charges are attributable across its business divisions.
BP PLC BP shares rose 1.43% to £4.31 Monday, on what proved to be an all-around poor trading session for the stock market, ...
Iraq and British oil major BP will sign a mammoth deal covering four Kirkuk oil and gas fields by the first week of February, ...
Read here for BPT Trustee's forced termination article, predicting potential equity wipeout and near term price target of ...
Analyst Doug Leggate of Wolfe Research maintained a Buy rating on BP (BP – Research Report), with a price target of $50.00.Stay Ahead of the ...
BP PLC ADR closed $9.18 below its 52-week high ($40.40), which the company reached on April 12th.
The page may have been moved or deleted. You can try searching for it below, move on or ask for help.
BP p.l.c. (NYSE:BP) shares fell premarket on Tuesday after the company updated fourth-quarter guidance. The company expects ...
In a regulatory filing, BP (BP) said, “Murray Auchincloss has recently undergone a planned medical procedure from which he is recovering well.
Iraq and British oil giant BP are set to finalize a major agreement involving four oil and gas fields in the northern city of Kirkuk in early February, ...
Oil giant BP has delayed an investor event due to be held in New York to allow boss Murray Auchincloss to recover after a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback